Close
  Indian J Med Microbiol
 

Figure 3: Interstitial cystitis risk score development. Bladder pain-risk score development. (a-c) Although statistically different, individual cytokine expression alone is not sufficient to classify controls and NHIC/bladder pain syndrome patients from HIC/bladder pain syndrome patients due to overlap between groups. (d) The bladder pain-risk score, a combination of urinary biomarkers, can successfully distinguish HIC/bladder pain syndrome patients for both the IP4IC training set and P3 validation set. (e) Receiver operating characteristic curve. The strong area under the curve values for IP4IC/bladder pain syndrome training

Figure 3: Interstitial cystitis risk score development. Bladder pain-risk score development. (a-c) Although statistically different, individual cytokine expression alone is not sufficient to classify controls and NHIC/bladder pain syndrome patients from HIC/bladder pain syndrome patients due to overlap between groups. (d) The bladder pain-risk score, a combination of urinary biomarkers, can successfully distinguish HIC/bladder pain syndrome patients for both the IP4IC training set and P3 validation set. (e) Receiver operating characteristic curve. The strong area under the curve values for IP4IC/bladder pain syndrome training